undamentalytics Newsletter
Sign in

Bausch & Lomb Corp income statement

In fiscal 2025, Bausch & Lomb Corp reported revenue of $5.10bn, up 6.5% on the year before, operating income of $113m (a 2.2% margin) and net income of −$360m, or −$1.02 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue3,4123,7653,7684,1464,7915,1015,418
Research and development253271307324343371400
Selling, general and administrative1,2531,3891,4781,7362,0822,2342,252
Operating income260329207130162113383
Interest expense00146283399421383
Income before tax29031873−166−234−317−4
Income tax3071255882713599
Net income−181826−260−317−360−111
Diluted EPS−$0.05$0.52$0.02−$0.74−$0.90−$1.02−$0.31
Diluted shares (average)350m350m350m351m352m354m357m
EBITDA702744586512598534787

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BLCO vs RMDBLCO vs DXCMBLCO vs STEBLCO vs IDXX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Bausch & Lomb Corp's SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Bausch & Lomb Corp.